FDA Ushers Out Known DMAA, Closes Dietary Ingredient Door
This article was originally published in The Tan Sheet
Executive Summary
USPlabs says it will reformulate its DMAA supplements, although it “stands by the safety and legality” of the products. FDA says “credible science” shows DMAA is not a botanical, not a dietary ingredient and will not be accepted in an NDI notification.
You may also be interested in...
DMAA, Other Stimulants Cast Shadow Over FDA Supplement Regulation – Study
Six workout and weight loss brands contained DMAA and three other stimulants, according to a study in the Journal Clinical Toxicology. Researchers concluded consumers must be informed of risk so they know to check labels for three substances that indicate the presence of the stimulants.
Five Shanghai Suspects Charged After FDA Undercover Work On Spiked Supplements
One of the undeclared stimulant ingredients, 2-amino-6-methylheptane, or DMHA, is new on FDA's radar for violative ingredients used in products marketed as dietary supplements, while the other, 1,3-dimethylamylamine, DMAA, has long been a target of agency enforcement in the supplement sector.
BMPEA In Supplements Spells Trouble To Researchers; FDA Has Different Idea
Researchers say beta-methylphenylethylamine – BMPEA – is a synthetic stimulant and they found it in 11 of 21 supplement products labeled as containing “Acacia rigidula.” FDA also has looked at BMPEA in supplements and says there is not “a specific safety concern at this time.”